|

Non-Investigational Antibody-Drug Conjugates (ADC) Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Non-Investigational ADC

Top Sponsors

  • University of California, San Francisco1

Indications

  • Metastatic Triple-Negative Breast Carcinoma1
  • Metastatic Triple Negative Breast Cancers1
  • HER2-Negative Breast Carcinoma1
  • Metastatic Breast Cancer1
  • HR+/HER2- Breast Cancer1

San Francisco, California1 trial

Prospective Registry of ADC as First- and Second-line Treatment for Breast Cancer

University of California, San Francisco

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.